Released May 11, 2026, after the close
10-Q filed May 11, 2026, 41 days after period end · 0001636422-26-000066
Q1 2026 · 10-Q
Revenue$70.76M$70.76M −10.9% vs Q1 2025−5.3% vs Q4 2025
Net Income-$111.03M-$111.03M N/M vs Q1 2025N/M vs Q4 2025
EPS Diluted-$1.53-$1.53 N/M vs Q1 2025no prior Q4 2025 on file
Operating Income-$106,477,000N/M
Operating Cash Flow$18,511,000+6,511.1%
Free Cash Flowderived$18,173,000N/M
Margins · derived
Operating margin-150.5%−125.1 pt vs Q1 2025
Net margin-156.9%−127.0 pt vs Q1 2025
What the release said
The release
Same quarter
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Revenue | $70.76M | $79.41M | $74.72M | $73.87M |
| Net Income | -$111.03M | -$23.74M | -$20.59M | -$33.19M |
| EPS Diluted | -$1.53 | -$0.35 | -$0.35 | -$0.60 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR